To include your compound in the COVID-19 Resource Center, submit it here.

Eli Lilly beats Street

Eli Lilly and Co. (NYSE:LLY) reported 2Q11 non-GAAP EPS of $1.18, beating by a penny the Street's

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE